Kelly Stahl

Dr. Kelly Stahl

Penn State College of Medicine
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2020 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
Kelly StahlKelly Stahl
Kelly Stahl
WWWilliam Wong
William Wong
DDDaleela Dodge
Daleela Dodge
ABAshton Brooks
Ashton Brooks
CMChristopher McLaughlin
Christopher McLaughlin
CSChan Shen
Chan Shen

24 December 2020 in Current Oncology
Verified
Journal Article
Open access
PDF file
Kelly StahlKelly Stahl
Kelly Stahl
EOElizabeth Olecki
Elizabeth Olecki
MDMatthew E. Dixon
Matthew E. Dixon
JPJune Peng
June Peng
MTMadeline B. Torres
Madeline B. Torres
CSChan Shen
Chan Shen
Gastric cancer is the third most common cause of cancer deaths worldwide. Despite evidence-based recommendation for treatment, the current treatment patterns for all stages of gastric cancer remain largely unexplored. This study investigates trends in the treatments and survival of gastric cancer. The National Cancer Database was used to identify gastric adenocarcinoma patients from 2004–2016. Chi-square tests were used to examine subgroup differences between disease stages: Stage I, II/III and IV. Multivariate analyses identified factors associated with the receipt of guideline concordant care. The Kaplan–Meier method was used to assess three-year overall survival. The final cohort included 108,150 patients: 23,584 Stage I, 40,216 Stage II/III, and 44,350 Stage IV. Stage specific guideline concordant care was received in only 73% of patients with Stage I disease and 51% of patients with Stage II/III disease. Patients who received guideline consistent care had significantly improved survival compared to those who did not. Overall, we found only moderate improvement in guideline adherence and three-year overall survival during the 13-year study time period. This study showed underutilization of stage specific guideline concordant care for stage I and II/III disease.

1 October 2021 in Journal of Surgical Research
Verified
Journal Article
Closed access
WWWilliam G. Wong
William G. Wong
Kelly StahlKelly Stahl
Kelly Stahl
EOElizabeth J. Olecki
Elizabeth J. Olecki
RHRolfy Perez Holguin
Rolfy Perez Holguin
CPColette Pameijer
Colette Pameijer
CSChan Shen
Chan Shen

1 February 2022 in Journal of Surgical Research
Verified
Journal Article
Closed access
Kelly StahlKelly Stahl
Kelly Stahl
DDDaleela Dodge
Daleela Dodge
EOElizabeth J. Olecki
Elizabeth J. Olecki
RHRolfy Perez Holguin
Rolfy Perez Holguin
CMChristopher McLaughlin
Christopher McLaughlin
CSChan Shen
Chan Shen

26 August 2020 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
EOElizabeth Olecki
Elizabeth Olecki
Kelly StahlKelly Stahl
Kelly Stahl
JPJune S. Peng
June S. Peng
MDMatthew Dixon
Matthew Dixon
NGNiraj J. Gusani
Niraj J. Gusani
CSChan Shen
Chan Shen

1 October 2020 in Journal of the American College of Surgeons
Verified
Journal Article
Open access
PDF file
EOElizabeth Olecki
Elizabeth Olecki
Kelly StahlKelly Stahl
Kelly Stahl
MTMadeline Torres
Madeline Torres
JPJune Peng
June Peng
MDMatthew Edmund Boyd Dixon
Matthew Edmund Boyd Dixon
NGNiraj Gusani
Niraj Gusani
Up to 70% of clinically stage I (cStage) pancreatic cancer patients are upstaged to a higher pathologic stage (pStage). Despite a majority of patients being upstaged after resection, risk factors and the effect of upstaging on overall survival (OS) are not well defined.